Friends of NPACE Podcast | Season 2 Episode 18: Pain in the head! Why migraines matter in primary care.
-
Register
- User - Free!
In this Friends of NPACE Podcast, Dr. Amy Bruno PhD, ANP-BC joins host Terri Schmitt to discuss important statistics on migraine headaches, diagnosis, and first stages of treatment. This podcast is supported by a generous educational grant by Haleon. This podcast is available for 0.5 CE Category 1 CME credit and 0.5 pharmacology credits.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
This session is supported by an educational grant from Haleon.
Credits: 0.50 Contact Hours; 0.50 are Pharmacology
CME Credits: 0.5 CME Category 1
Expiration Date: June 11th, 2026
FREE
Amy Bruno, PhD, ANP-BC
Primary Care Provider; Galileo Health
Lecturer; MGH Institute of Health Professions School of Nursing
Amy Bruno is currently a nurse practitioner providing virtual primary care with Galileo Health, Inc. She also is a term lecturer at MGH Institute of Health Professions School of Nursing and teaches in the Adult-Gero Primary Care NP Program. Amy has previously worked in the neurology field for over 10 years providing care to clients in the inpatient and outpatient settings. In 2016 she completed her Ph.D. in nursing at UMASS Dartmouth and her research interests include symptom management and quality of life in individuals with movement and headache disorders.
After listening to this podcast learners will:
- Define the risk factors, etiology, incidence, and prevalence of migraine, including the differentiation between headache and migraine
- Review key principles in patient screening and management
- Identify decision-making strategies for therapeutic selection and behavior modification, specifically over-the-counter options and alternatives for migraine management
- Foster patient educational opportunities for migraine awareness and information
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 0.50 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720.
Faculty
Contributing faculty, Amy Bruno, PhD, ANP-BC has disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
This session is supported by an educational grant from Haleon.
